Taysha Gene Therapies, Inc. Common Stock
TSHA •
Buy Open
Signal type
Buy
Status
Open
Open Price
$4.78
Stop Loss
$4.32
Performance
-1.46%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $4.78
Stop Loss $4.32
Timespan Day
Company Profile
Name Taysha Gene Therapies, Inc. Common Stock
Ticker TSHA
Market Cap $611.98M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $4.71
List Date Sep 24, 2020
Description
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
Website Open Company Website